✨ Free AI Report
Myomo Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Myomo Inc.
Company Research

Myomo Inc.: Business Overview, Financials & Competitive Analysis

Myomo Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Myomo represents a compelling opportunity in the emerging powered exoskeleton market with proven technology and expanding clinical adoption, though execution risk and cash flow management remain key concerns. Myomo operates in a high-growth medical device segment with FDA clearance and expanding reimbursement coverage. However, the company faces typical biomedical small-cap.

What is Myomo Inc.'s industry? Myomo Inc. (myomo.com) operates in Medical Devices - Powered Exoskeletons & Rehabilitation Robotics. AskCyborg classifies Myomo Inc. under Medical Devices - Powered Exoskeletons & Rehabilitation Robotics in its company registry.

Myomo is a medical robotics company specializing in wearable myoelectric orthoses (powered exoskeletons) for patients with upper limb paralysis. The company develops and commercializes MyoPro, a FDA-cleared device tha...

6/ 10Solid

Cyborg Score thesis

Myomo represents a compelling opportunity in the emerging powered exoskeleton market with proven technology and expanding...

Read the full analyst-debate transcript →
Industry Medical Devices - Powered Exoskeletons & Rehabilitation Robotics
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Myomo Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Myomo Inc.

AskCyborg analysts argue the bull and bear cases for Myomo Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Myomo Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Myomo Inc. Overview

Pro stress-test →

Myomo is a medical robotics company specializing in wearable myoelectric orthoses (powered exoskeletons) for patients with upper limb paralysis. The company develops and commercializes MyoPro, a FDA-cleared device that helps restore arm and hand function to stroke, brachial plexus injury, and other upper limb paralysis patients through powered muscle-activated movement.

Strategic Profile

Pro stress-test →

Myomo is positioned in the rehabilitation and assistive technology market, leveraging proprietary electromyography (EMG) technology and robotics. The company targets hospital rehabilitation centers, outpatient facilities, and home care settings, with potential for expansion into broader neurological recovery applications.

Competitive Landscape

Pro stress-test →

Myomo faces competition from traditional occupational therapy approaches and emerging exoskeleton manufacturers. Larger medical device companies (Stryker, Medtronic) may enter the space, while international competitors develop lower-cost alternatives. Myomo's key advantage is FDA clearance and clinical evidence.

Industry Context

Myomo Inc. operates in Medical Devices - Powered Exoskeletons & Rehabilitation Robotics.

Key facts

Founded: 2006 · Headquarters: Boston, Massachusetts

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Myomo Inc..

  • MyoPro is the only FDA-cleared wearable exoskeleton device for upper limb paralysis with expanding insurance coverage
  • Market opportunity for stroke and neurological injury rehabilitation is substantial and growing globally
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2025Expansion of insurance reimbursement coverage for MyoPro device
  • 2025Increased adoption in hospital and rehabilitation center networks
  • +1 moreTrack every material event for Myomo Inc. as it happens. Explore monitoring →
Get alerted when Myomo Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Stroke Recovery TherapyConventional rehabilitation without powered assistance→Exoskeleton PlatformsEmerging powered exoskeleton competitors globally→Assistive DevicesPotential future entrants in powered orthotic space→

Compare Myomo Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Myomo Inc. operates in Medical Devices - Powered Exoskeletons & Rehabilitation Robotics. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Powered Exoskeletons & Rehabilitation Robotics research →
NEW · MCP server

Ask your AI assistant about Myomo Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Myomo Inc. and its top competitor on Cyborg Score”
“What did Myomo Inc. do this quarter?”
“Is Myomo Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Myomo Inc. do?+
Myomo is a medical robotics company specializing in wearable myoelectric orthoses (powered exoskeletons) for patients with upper limb paralysis. The company develops and commercializes MyoPro, a FDA-cleared device tha...
What is Myomo Inc.'s Cyborg Score?+
Myomo Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Myomo Inc.'s main competitors?+
Named competitors include Stroke Recovery Therapy, Exoskeleton Platforms, Assistive Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Myomo Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Myomo Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Myomo Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.